The Enterprise Value as of December 2024 (TTM) for Exicure, Inc. (XCUR) is 50.55M

According to Exicure, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 50.55M. This represents a change of 109.08% compared to the average of 24.18M of the last 4 quarters.

Exicure, Inc. (XCUR) Historical Enterprise Value (quarterly & annually)

How has XCUR Enterprise Value performed in the past?

The mean historical Enterprise Value of Exicure, Inc. over the last ten years is 461.43M. The current 50.55M Enterprise Value has changed 995.54% with respect to the historical average. Over the past ten years (40 quarters), XCUR's Enterprise Value was at its highest in in the June 2018 quarter at 1.11B. The Enterprise Value was at its lowest in in the March 2016 quarter at 0.

Exicure, Inc. (XCUR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Exicure, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Exicure, Inc. (XCUR) Average Enterprise Value

How has XCUR Enterprise Value performed in the past?

The current Enterprise Value of Exicure, Inc. (XCUR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Exicure, Inc. (XCUR) Enterprise Value vs. Peers

How is XCUR’s Enterprise Value compared to its peers?

Exicure, Inc.’s Enterprise Value is greater than Ikena Oncology, Inc. (37.04M), less than Enochian Biosciences, Inc. (167.08M), less than Eliem Therapeutics, Inc. (0), greater than HCW Biologics Inc. (26.86M), less than ZIVO Bioscience, Inc. (78.24M), greater than RenovoRx, Inc. (21.40M), greater than Tempest Therapeutics, Inc. (33.01M), less than Catalyst Biosciences, Inc. (1.01B), less than scPharmaceuticals Inc. (130.15M), less than Milestone Pharmaceuticals Inc. (139.88M), less than Oncolytics Biotech Inc. (88.79M), less than Seres Therapeutics, Inc. (190.70M), less than aTyr Pharma, Inc. (138.44M), greater than Lumos Pharma, Inc. (24.19M), greater than Marker Therapeutics, Inc. (21.16M), greater than Protagenic Therapeutics, Inc. (2.29M), greater than PMV Pharmaceuticals, Inc. (40.53M), greater than Imunon, Inc. (2.77M), greater than Cyclacel Pharmaceuticals, Inc. (-985182.00), greater than Histogen Inc. (-4487565.00), less than DiaMedica Therapeutics Inc. (221.15M),

Build a custom stock screener for Exicure, Inc. (XCUR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exicure, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exicure, Inc. (XCUR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exicure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.